RxDoctor Payments Data

Brandy Bartholomew

Family · Lexington, TNNPI 1063802346

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 392 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,360in general payments, 2019–2025

Across 392 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • AstraZeneca$789
  • UCB, Inc.$584
  • AbbVie$534
  • Amneal Pharmaceuticals LLC$507
  • Argenx US, Inc.$459
  • plus $3K from 29 others

What the payments were for

  • Food & beverage$7,360100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,360 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Medicare billing

Part B allowed, 2024
$43,180
Medicare patients
274
Services billed
631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin118$1,180
Diclofenac Sodium46$535
Pregabalin26$200
Tizanidine Hcl23$145
Meloxicam42$105
Methylprednisolone18$100
Methocarbamol14$74
Cyclobenzaprine Hcl16$26
Diazepam17$9

Paid to pharmacies, not to this prescriber.

Other family in Lexington

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →